comscore ZanthoSyn sales pick up for Oahu-based Cardax | Honolulu Star-Advertiser
Business

ZanthoSyn sales pick up for Oahu-based Cardax

  • STAR-ADVERTISER

    David G. Watumull:

    The CEO of Cardax Inc. says it is building a strong foundational business model for growth in the U.S.

A Hawaii company gained ground in the first quarter selling what it promotes as a new synthetic remedy for inflammation after years of research and development that has consumed $56 million of investment capital. Read more

Scroll Up